Dr Agarwals Health Care Ltd

As of 06-Nov, Dr Agarwals Health Care Ltd's stock price is Rs 508.60, down 1.22%, with a recent decline in investor participation and performance worse than its sector. Despite a 3.55% gain over the past month, the stock's recent downward trend and reduced trading volume indicate cautious investor sentiment.

Dr Agarwal's Hea has shown significant growth over the past three years, with net sales increasing from 1,017.98 Cr in Mar'23 to 1,711.00 Cr in Mar'25, and operating profit rising from 283.86 Cr to 502.40 Cr during the same period, alongside a substantial increase in total assets. Overall, the company demonstrates a solid performance trajectory with rising revenues and profits.

As of 10-Oct, Dr Agarwals Health Care Ltd is experiencing a price increase to Rs. 533.00, reflecting a rise of 6.02% and hitting a new all-time high of Rs. 542. The stock has shown strong performance with a 6.72% gain over the past week and a 24.36% surge in the last month, outperforming its sector and the benchmark Sensex.

As of 25-Sep, Dr Agarwals Health Care Ltd is currently priced at Rs 482.05, reflecting a 4.7% increase. Despite outperforming the market, a significant drop in delivery volume raises concerns about sustained investor interest.

As of 24-Sep, Dr Agarwals Health Care Ltd is priced at 459.25, down 0.21%, but has shown a strong 3.94% return over the past week, outperforming the Sensex. The stock is trading above key moving averages and has seen a significant increase in investor interest, indicating a potentially positive outlook despite the current decline.

As of 23-Sep, Dr Agarwals Health Care Ltd is trading at 459.40, reflecting a 0.85% increase and outperforming its sector. Despite a decline in investor participation, the stock shows strong upward momentum and adequate liquidity for trading.

As of 22-Sep, Dr Agarwals Health Care Ltd is priced at 455.00, down 0.24%, following a trend reversal after three days of gains. Despite a recent decline, the stock remains above key moving averages and has seen increased investor interest, although it has underperformed the Sensex over the past month.

As of 19-Sep, Dr Agarwals Health Care Ltd is currently priced at 450.45, reflecting a 1.45% increase and a total return of 2.49% over the last three days. Despite outperforming the sector and benchmark Sensex recently, there is a significant decline in investor participation, which may raise concerns about sustained interest in the stock.

As of 18-Sep, Dr Agarwals Health Care Ltd is currently priced at 444.00, reflecting a 0.49% increase and outperforming its sector today. The stock has shown strong upward momentum with significant investor interest, evidenced by a 101% rise in delivery volume compared to the 5-day average.

As of 17-Sep, Dr Agarwals Health Care Ltd is priced at 441.85, up 0.53%, but shows signs of selling pressure with a 47.4% drop in delivery volume compared to the 5-day average. Despite a 3.09% gain over the past week, the stock has declined 5.77% in the last month, underperforming the Sensex's 2.60% gain.

As of 16-Sep, Dr Agarwals Health Care Ltd is priced at 439.50, down 0.45%, and has underperformed its sector today. Despite a recent weekly gain of 3.93%, the stock has seen a significant decline in investor participation and a 6.27% drop over the past month, indicating a challenging environment.

As of 15-Sep, Dr Agarwals Health Care Ltd is seeing a price increase to Rs 441.50, up 1.94%, but with a significant drop in delivery volume by 75.62%, raising concerns about the sustainability of this trend. Despite outperforming the Sensex over the past week, the stock has underperformed over the past month, indicating volatility and potential caution among investors.

As of September 12, 2025, Dr Agarwal's Healthcare is considered very expensive and overvalued with a PE ratio of 160.64, significantly higher than its peers, and a low ROE of 4.58%, making it not a compelling investment at its current price of 433.10.

As of September 12, 2025, Dr Agarwal's Healthcare is considered very expensive with a PE ratio of 160.64, significantly higher than its peers, indicating it is overvalued despite slight recent stock outperformance against the Sensex.

As of September 12, 2025, Dr Agarwal's Healthcare is considered very expensive with a PE ratio of 160.64, significantly higher than its peers, indicating it is overvalued and has underperformed against the Sensex.

As of 12-Sep, Dr Agarwals Health Care Ltd's stock price is Rs 433.10, up 2.38% today, but it has declined 3.73% over the past month. The significant drop in delivery volume suggests reduced investor participation, indicating potential challenges ahead despite today's gains.

As of 11-September, Dr Agarwals Health Care Ltd's stock price is declining at 423.05, down 1.29%, and underperforming its sector. Despite being above longer-term moving averages, it has seen a significant drop in delivery volume and a 5.12% decline over the past month, indicating weak performance relative to the broader market.

As of 10-Sep, Dr Agarwals Health Care Ltd's stock price is at 428.60, up 1.35%. While it has shown short-term gains, it has underperformed over the past month compared to the broader market, with declining investor participation and no clear catalysts for its recent price movements.

As of 09-Sep, Dr Agarwals Health Care Ltd's stock price has declined to Rs 422.90, down 2.21%, and has underperformed its sector. Despite increased investor interest, the stock has shown negative trends over the past week and month, contrasting with the broader market's positive performance.